These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20467287)

  • 21. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
    Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N
    Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians.
    Wolday D; Hailu B; Girma M; Hailu E; Sanders E; Fontanet AL
    Ethiop Med J; 2003 Jun; 41 Suppl 1():67-73. PubMed ID: 15227883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
    Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
    Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers.
    Rubinstein A; Goldstein H; Pettoello-Mantovani M; Mizrachi Y; Bloom BR; Furer E; Althaus B; Que JU; Hasler T; Cryz SJ
    AIDS; 1995 Mar; 9(3):243-51. PubMed ID: 7755912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis.
    Payne H; Mkhize N; Otwombe K; Lewis J; Panchia R; Callard R; Morris L; Babiker A; Violari A; Cotton MF; Klein NJ; Gibb DM
    Lancet Infect Dis; 2015 Jul; 15(7):803-9. PubMed ID: 26043884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting seronegative-early HIV infections among adult versus student Kenyan blood donors, by using Stimmunology.
    Mumo J; Vansover A; Jehuda-Cohen T
    Exp Biol Med (Maywood); 2009 Aug; 234(8):931-9. PubMed ID: 19491368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of CD4+ lymphocyte count among HIV-seropositive and HIV-seronegative pregnant women in Dar es Salaam, Tanzania.
    Kapiga SH; Mwakagile D; Spiegelman D; Msamanga GI; Hunter D; Fawzi WW
    East Afr Med J; 2000 Apr; 77(4):206-11. PubMed ID: 12858905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
    Burastero SE; Gaffi D; Lopalco L; Tambussi G; Borgonovo B; De Santis C; Abecasis C; Robbioni P; Gasparri A; Lazzarin A; Celada F; Siccardi AG; Beretta A
    AIDS Res Hum Retroviruses; 1996 Mar; 12(4):273-80. PubMed ID: 8906987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus (HIV) type 1-specific B cell response in seronegative subjects at risk for HIV exposure.
    Angarano G; Fiore JR; Di Stefano M; Monno L
    J Infect Dis; 1996 Aug; 174(2):447-8. PubMed ID: 8699088
    [No Abstract]   [Full Text] [Related]  

  • 31. Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct.
    Detels R; Mann D; Carrington M; Hennessey K; Wu Z; Hirji KF; Wiley D; Visscher BR; Giorgi JV
    Immunol Lett; 1996 Jun; 51(1-2):29-33. PubMed ID: 8811341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease.
    Gori A; Rossi MC; Marchetti G; Trabattoni D; Molteni C; Cogliati M; Bandera A; Clerici M; Franzetti F
    AIDS; 2000 Aug; 14(12):1859-61. PubMed ID: 10985328
    [No Abstract]   [Full Text] [Related]  

  • 33. The downside of success: confirmation of HIV infection in early treated children.
    Sutcliffe CG; Moss WJ
    Lancet Infect Dis; 2015 Jul; 15(7):751-2. PubMed ID: 26043883
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of T-lymphocyte subsets and phenotypes between HIV-positive subjects and HIV-negative subjects.
    Chen X; Chen G; Xiao B; Shi W; Xu H; Gao K
    Chin Med Sci J; 2001 Sep; 16(3):185. PubMed ID: 12899337
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of human immunodeficiency virus type 1 by PCR before seroconversion in high-risk individuals who remain seronegative for prolonged periods.
    Gorriño MT; Campelo C; Suarez MD; Santamaría A; Malave C; Cisterna R
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):271-6. PubMed ID: 8050445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum protein electrophoresis in HIV seropositive and seronegative pregnant women.
    Kapsenberg LC; Cronjé HS; van Jaarsveld H
    Int J Gynaecol Obstet; 2004 Mar; 84(3):254-8. PubMed ID: 15001376
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid in vitro detection of HIV-1-specific antibody secretion by cells-culture with virus antigens.
    Caterino-de-Araujo A
    Mem Inst Oswaldo Cruz; 1992; 87(2):239-47. PubMed ID: 1308570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [AIDS phobia (its clinical picture and typology)].
    Medvedeva SB
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(6):73-6. PubMed ID: 8160512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A seroepidemiologic survey of immunity against poliomyelitis in a group of HIV positive and HIV negative drug addicts.
    Pregliasco F; Minolfi V; Boschin A; Andreassi A; Profeta ML
    Eur J Epidemiol; 1995 Dec; 11(6):693-5. PubMed ID: 8861854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular findings in HIV-1 positive and HIV-1 negative participants in a rural population-based cohort in Uganda.
    Morgan D; Jones C; Whitworth J; Ross A; Johnson G
    Int Ophthalmol; 1998-1999; 22(3):183-92. PubMed ID: 10548465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.